14 小时
Vietnam Investment Review on MSNVietnam accelerates in high-tech pharmaceutical raceThe report indicates a compound annual growth rate of 10.4 per cent per year from 2022 to 2024, with on-year growth of 9 per ...
StockStory.org on MSN4 天
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic ...The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Ever bought a pair of ‘abibas’ slides from Pettah? Or some ‘Colvin Klean’ underwear? No harm if you have (reputational harm ...
The entry of generic products into the market helps to reduce prices for branded products and increase competition in the ...
Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...
Geropharm said its replica of Ozempic — called Semavic — sold more than a million packs in Russia in its first full year on the market. According to Russian analytics company DSM Group, it was one of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果